Amrou Sarraj, MD

Amrou Sarraj, MD

Associate Professor, Department of Neurology
Director, Vascular Neurology Fellowship Program

Dr. Sarraj graduated from Damascus University Medical School, ranked number 3 in his class. With the advent of mechanical thrombectomy becoming an approved treatment for acute stroke, his work is focused on optimizing stroke outcomes by developing methods to select patients who will maximally benefit from acute stroke therapies. With industry grants from Stryker, he is conducting the first investigator-initiated prospective studies to determine what variables derived from simple versus advanced imaging will optimally select patients for endovascular therapy for large artery occlusions both in early and late time windows. Dr. Sarraj was awarded the American Heart Association Mordecai Globus Award in 2012 for devising a scoring system to assess patient outcomes after endovascular treatment – the HIAT-2 score, which is used in clinical practice. Dr. Sarraj is also the stroke fellowship director at UTHealth, the largest training program in the United States, he is the director for general neurology services at UTHealth, and he is the recipient of numerous teaching awards at UTHealth

Research News


Access of US Population to Thrombectomy Capable Hospitals

Dr. Amrou Sarraj won the Emergency Medicine Award at the AHA International Stroke Conference for his work mapping access of US residents to hospitals that can perform thrombectomy for acute stroke.

“Current direct EVT [endovascular thrombectomy] access in the United States is suboptimal under predominate EMS routing protocols,” according to Dr. Sarraj. “Only in eight states did the coverage exceed 25% of the population, and nine states had coverage for less than 10% of the population. These results reflect limited access to an effective treatment that improves clinical outcomes in patients with large strokes and prevent potentially devastating disability.”

Dr. Sarraj shows in his paper using mapping methodology that bypassing non-EVT centers, when the added bypass time is less than 15 minutes, results in an anticipated overall U.S. gain in access of about 17%, or 52 million people. The second approach, converting the top 10% of stroke centers that currently do not provide EVT to centers that do offer EVT, would lead to expanded access for about 23 million additional Americans.

Full article available

Clinical Trial

Evaluation of endovascular thrombectomy efficacy and safety

Select 2 logo

Starting August 2019, a worldwide clinical trial to evaluate endovascular thrombectomy efficacy and safety in acute stroke patients with large ischemic core infarcts will get underway under the leadership of Amrou Sarraj, MD, associate professor of neurology.


Education & Training

Medical Degree
Damascus University College of Medicine, Damascus, Syria
University of Illinois-Advocate Christ Medical Center, Oak Lawn, IL
Neurology, The University of Texas Health Science Center at Houston, Houston, TX
Vascular Neurology, The University of Texas Health Science Center at Houston, Houston, TX
Neurophysiology, The University of Texas Health Science Center at Houston, Houston, TX